Topics

No keywords indexed for this article. Browse by subject →

References
30
[1]
Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845–848 (1999). 10.1126/science.283.5403.845
[2]
Peled, A. et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J. Clin. Invest. 104, 1199–1211 (1999). 10.1172/jci7615
[3]
McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K. & Palis, J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213, 442–456 (1999). 10.1006/dbio.1999.9405
[4]
Kollet, O. et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 112, 160–169 (2003). 10.1172/jci17902
[5]
Askari, A.T. et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697–703 (2003). 10.1016/s0140-6736(03)14232-8
[6]
Yamaguchi, J. et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107, 1322–1328 (2003). 10.1161/01.cir.0000055313.77510.22
[7]
Hitchon, C. et al. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum. 46, 2587–2597 (2002). 10.1002/art.10520
[8]
Tepper, O.M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781–2786 (2002). 10.1161/01.cir.0000039526.42991.93
[9]
Amara, A. et al. Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine. J. Biol. Chem. 274, 23916–23925 (1999). 10.1074/jbc.274.34.23916
[10]
Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721–732 (2003). 10.1038/nrc1187
[11]
Huang, L.E., Gu, J., Schau, M. & Bunn, H.F. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987–7992 (1998). 10.1073/pnas.95.14.7987
[12]
Forsythe, J.A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604–4613 (1996). 10.1128/mcb.16.9.4604
[13]
Campbell, J. et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279, 381–384 (1998). 10.1126/science.279.5349.381
[14]
Reiss, K., Mentlein, R., Sievers, J. & Hartmann, D. Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 115, 295–305 (2002). 10.1016/s0306-4522(02)00307-x
[15]
Ratajczak, M.Z. et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21, 363–371 (2003). 10.1634/stemcells.21-3-363
[16]
Kawamoto, A. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634–637 (2001). 10.1161/01.cir.103.5.634
[17]
Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964–967 (1997). 10.1126/science.275.5302.964
[18]
Hill, J.M. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593–600 (2003). 10.1056/nejmoa022287
[19]
Signoret, N. et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139, 651–664 (1997). 10.1083/jcb.139.3.651
[20]
Sweeney, E., Lortat-Jacob, H., Priestley, G., Nakamoto, B. & Papayannopoulou, T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 99, 44–51 (2002). 10.1182/blood.v99.1.44
[21]
Hattori, K. et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354–3360 (2001). 10.1182/blood.v97.11.3354
[22]
Nagasawa, T. et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638 (1996). 10.1038/382635a0
[23]
Zou, Y., Kottmann, A., Kuroda, M., Taniuchi, I. & Littman, D. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599 (1998). 10.1038/31269
[24]
Harrison, J.S., Rameshwar, P., Chang, V. & Bandari, P. Oxygen saturation in the bone marrow of healthy volunteers. Blood 99, 394 (2002). 10.1182/blood.v99.1.394
[25]
Staller, P. et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307–311 (2003). 10.1038/nature01874
[26]
Elson, D.A. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev. 15, 2520–2532 (2001). 10.1101/gad.914801
[27]
Rivard, A. et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J. Biol. Chem. 275, 29643–29647 (2000). 10.1074/jbc.m001029200
[28]
Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001). 10.1038/35065016
[29]
Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow–derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434–438 (1999). 10.1038/7434
[30]
Dimmeler, S. et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391–397 (2001). 10.1172/jci200113152
Cited By
2,141
Diabetes/Metabolism Research and Re...
International Journal of Molecular...
Circulation Research
Pathological angiogenesis: mechanisms and therapeutic strategies

Andrew C. Dudley, Arjan W. Griffioen · 2023

Angiogenesis
International Journal of Molecular...
International Journal of Molecular...
Molecular Biology Reports
Treatment of Diabetic Kidney Disease: Current and Future

Tomotaka Yamazaki, Imari Mimura · 2021

Diabetes & Metabolism Journal
Journal of Clinical Medicine
Arteriosclerosis, Thrombosis, and V...
Journal of Clinical Immunology
The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

Eva M. García-Cuesta, César A. Santiago · 2019

Frontiers in Endocrinology
Metrics
2,141
Citations
30
References
Details
Published
Jul 04, 2004
Vol/Issue
10(8)
Pages
858-864
License
View
Cite This Article
Daniel J Ceradini, Anita R Kulkarni, Matthew J Callaghan, et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858-864. https://doi.org/10.1038/nm1075
Related

You May Also Like

The biology of VEGF and its receptors

Napoleone Ferrara, Hans-Peter Gerber · 2003

7,614 citations

Microenvironmental regulation of tumor progression and metastasis

Daniela F Quail, Johanna A Joyce · 2013

6,673 citations

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies, Edward W. Roberts · 2018

5,090 citations